enVVeno stockholders reject 2025 equity plan; authorize reverse stock split

enVVeno Medical Corp

Elected Jenusaitis (3.47M for, 1.80M withheld) and Berman (4.73M for, 0.54M withheld) as Class II directors.
Advisory say-on-pay passed: 3.19M for, 1.96M against, 5.79M broker non-votes.
Stockholders voted AGAINST the 2025 Equity Incentive Plan (2.48M for, 2.62M against); 2016 plan remains.
Approved reverse stock split authorization (7.31M for, 1.58M against) at ratio of 1:5 to 1:35 at Board discretion.
Ratified CBIZ CPAs P.C. as auditor for FY2025 (10.86M for, 0.14M against).

item 5.07item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.